[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334284-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334284-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","rural-versus-urban-genitourinary-cancer-incidence-and-mortality-in-pennsylvania-1990-2019","Rural Versus Urban Genitourinary Cancer Incidence and Mortality in Pennsylvania: 1990-2019","","The study describes incidence and mortality patterns of genitourinary (GU) cancers in rural versus urban Pennsylvania counties from 1990 to 2019. Age-adjusted incidence and mortality rates for prostate, bladder, and kidney cancers were calculated using Pennsylvania Cancer Registry data, with rurality defined by population density. Joinpoint regression estimated average annual percent changes (AAPCs). Overall GU cancer incidence and mortality declined in both settings; prostate mortality declined similarly. Kidney incidence rose in rural and urban counties, while kidney mortality decreased in urban and remained stable in rural counties. Bladder incidence and mortality were unchanged.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/rural-versus-urban-genitourinary-cancer-incidence-and-mortality-in-pennsylvania-1990-2019/334284/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/rural-versus-urban-genitourinary-cancer-incidence-and-mortality-in-pennsylvania-1990-2019/334284.png","ImageObject",300,407,{"name":42,"@type":43},"Genevieve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s main objective regarding rural vs urban counties?","Question",{"text":63,"@type":64},"To describe how genitourinary (GU) cancer incidence and mortality changed in rural and urban Pennsylvania counties from 1990 to 2019.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which GU cancers were analyzed in the study?",{"text":68,"@type":64},"Prostate, bladder, and kidney cancers were included, while testicular and penile cancers were excluded.",{"name":70,"@type":61,"acceptedAnswer":71},"How were trends in incidence and mortality measured over time?",{"text":72,"@type":64},"Age-adjusted rates were modeled using joinpoint regression to estimate average annual percent changes (AAPCs) for incidence and mortality from 1990 to 2019.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334284,1790158359,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":4},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article  \nRural Versus Urban Genitourinary Cancer Incidence and Mortality in Pennsylvania: 1990–2019  \nJonathan Pham, Ahmad N. Alzubaidi, Jay D. Raman and Tullika Garg *  \nCitation: Pham, J.; Alzubaidi, A.N.; Raman, J.D.; Garg, T. Rural Versus Urban Genitourinary Cancer Incidence and Mortality in Pennsylvania: 1990–2019 . Curr. Oncol.  \n2024, 31, 8110–8117. [https://](https://)  \n[doi.org/10.3390/curroncol31120597](doi.org/10.3390/curroncol31120597)  \nReceived: 21 November 2024  \nRevised: 17 December 2024  \nAccepted: 19 December 2024  \nPublished: 23 December 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nDepartment of Urology, Penn State Health Milton S. Hershey Medical Center, Hershey, PA 17033, USA;  \n[jpham1@pennstatehealth.psu.edu](jpham1@pennstatehealth.psu.edu) (J.P.); [analzubaidi@gmail.com](analzubaidi@gmail.com) (A.N.A.);  \n[jraman@pennstatehealth.psu.edu](jraman@pennstatehealth.psu.edu) (J.D.R.)  \n* Correspondence: [tgarg@pennstatehealth.psu.edu](tgarg@pennstatehealth.psu.edu)  \nAbstract: Our aim was to describe the incidence and mortality of genitourinary (GU) cancers in rural and urban Pennsylvania counties. We calculated age-adjusted incidence and mortality rates of GU (prostate, bladder, and kidney) cancers from 1990 to 2019 in the Pennsylvania Cancer Registry. We defined rurality using the Center for Rural Pennsylvania’s population density-based definition. We modeled average annual percent changes (AAPC) in age-adjusted incidence and mortality rates using joinpoint regression. Overall GU cancer incidence decreased in rural and urban counties (AAPC −7.5%, p = 0.04 and AAPC −6.6%, p = 0.02, respectively) . Prostate cancer incidence decreased in rural and urban counties by −10.5%(p = 0.02) and −9.1%(p = 0.01), respectively. Kidney cancer incidence increased in both rural and urban counties, respectively (AAPC = +11.2, p = 0.002 and +9.3%, p = 0.01) . GU cancer mortality decreased in rural and urban counties (AAPC = −11.6, p = 0.047 and AAPC −12.2, p = 0.01, respectively) . Prostate cancer mortality decreased at similar rates in rural and urban counties (AAPC −15.5, p = 0.03 and −15.4, p = 0.02, respectively) . Kidney cancer mortality decreased in urban (AAPC −6.9% p = 0.03) but remained stable in rural counties. Bladder cancer incidence and mortality were unchanged in both types of counties. Over three decades, GU cancer incidence and mortality decreased across Pennsylvania counties.  \nKeywords: bladder cancer; kidney cancer; prostate cancer; rural health; health disparities; epidemiology; urologic oncology; cancer control  \n1. Introduction  \nThe burden of genitourinary (GU) cancers including prostate, bladder, and kidney cancer is enormous, accounting for approximately 25% of all cancer survivors in the United States (U.S) [1]. Prostate cancer is [the most common cancer diagnosed in U.S. men](the most common cancer diagnosed in U.S. men), bladder cancer is the fourth most common cancer in men and the sixth most common across both sexes and kidney cancer is the ninth most common cancer. Pennsylvania ranks twentysecond among U.S. states in cancer mortality rates, and cancer is the second leading cause of death in the state [2] . Prostate cancer and bladder cancer are projected to be in the top five cancers for new diagnoses in Pennsylvania in 2023, with an anticipated 13,210 and 4270 new cases, respectively [3,4] .  \nCancer incidence and mortality rates have been decreasing overall in the United States; however, rural areas have seen slower declines in cancer mortality compared to urban areas, which may be in part due to higher death rates from certain cancers including prostate [4,5] . Despite the hi","cbCaiuJ7i1CZd5yQ","https://ap.wps.com/l/cbCaiuJ7i1CZd5yQ","pdf",829695,"English","# Introduction\n# Materials and Methods\n## Data","[{\"question\":\"What was the study’s main objective regarding rural vs urban counties?\",\"answer\":\"To describe how genitourinary (GU) cancer incidence and mortality changed in rural and urban Pennsylvania counties from 1990 to 2019.\"},{\"question\":\"Which GU cancers were analyzed in the study?\",\"answer\":\"Prostate, bladder, and kidney cancers were included, while testicular and penile cancers were excluded.\"},{\"question\":\"How were trends in incidence and mortality measured over time?\",\"answer\":\"Age-adjusted rates were modeled using joinpoint regression to estimate average annual percent changes (AAPCs) for incidence and mortality from 1990 to 2019.\"}]","Rural Versus Urban Genitourinary Cancer Incidence and Mortality in Pennsylvania: 1990-2019 | PDF",1790006119]